Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Balchem Cp (BCPC)

Balchem Cp (BCPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,124,335
  • Shares Outstanding, K 32,121
  • Annual Sales, $ 799,020 K
  • Annual Income, $ 96,100 K
  • 60-Month Beta 0.59
  • Price/Sales 5.03
  • Price/Cash Flow 27.97
  • Price/Book 4.46
Trade BCPC with:

Options Overview Details

View History
  • Implied Volatility 26.91% ( +0.40%)
  • Historical Volatility 28.31%
  • IV Percentile 66%
  • IV Rank 58.43%
  • IV High 35.04% on 05/11/22
  • IV Low 15.48% on 11/11/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 383
  • Open Int (30-Day) 261

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.85
  • Number of Estimates 1
  • High Estimate 0.85
  • Low Estimate 0.85
  • Prior Year 0.92
  • Growth Rate Est. (year over year) -7.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.73 +5.95%
on 07/14/22
136.88 -5.00%
on 07/29/22
+1.84 (+1.44%)
since 07/11/22
3-Month
110.15 +18.05%
on 06/21/22
136.88 -5.00%
on 07/29/22
+13.86 (+11.93%)
since 05/11/22
52-Week
110.15 +18.05%
on 06/21/22
174.29 -25.39%
on 11/23/21
-0.46 (-0.35%)
since 08/11/21

Most Recent Stories

More News
Balchem (BCPC) Q2 2022 Earnings Call Transcript

BCPC earnings call for the period ending June 30, 2022.

BCPC : 129.57 (+0.91%)
Blachem (BCPC) Q2 Earnings and Revenues Top Estimates

Blachem (BCPC) delivered earnings and revenue surprises of 9.52% and 6.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

BCPC : 129.57 (+0.91%)
AVD : 20.00 (+1.11%)
Balchem Corporation Reports Second Quarter Sales of $236.7 Million, Net Earnings of $29.8 Million, GAAP EPS of $0.92, and Adjusted EPS of $1.07

NEW HAMPTON, N.Y., July 29, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net earnings of $29.8 million for...

BCPC : 129.57 (+0.91%)
Blachem (BCPC) Upgraded to Buy: Here's What You Should Know

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BCPC : 129.57 (+0.91%)
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 29, 2022

NEW HAMPTON, N.Y., July 15, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday,...

BCPC : 129.57 (+0.91%)
Balchem Corporation Completes Acquisition of Kappa Bioscience AS

NEW HAMPTON, N.Y., June 21, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and...

BCPC : 129.57 (+0.91%)
What Makes Blachem (BCPC) a New Strong Buy Stock

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BCPC : 129.57 (+0.91%)
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

NEW HAMPTON, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and...

BCPC : 129.57 (+0.91%)
3 Reasons Growth Investors Will Love Blachem (BCPC)

Blachem (BCPC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

BCPC : 129.57 (+0.91%)
Balchem (BCPC) Q1 2022 Earnings Call Transcript

BCPC earnings call for the period ending March 31, 2022.

BCPC : 129.57 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Balchem Corporation provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Balchem Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health...

See More

Key Turning Points

3rd Resistance Point 132.58
2nd Resistance Point 130.81
1st Resistance Point 129.60
Last Price 129.57
1st Support Level 126.62
2nd Support Level 124.85
3rd Support Level 123.64

See More

52-Week High 174.29
Fibonacci 61.8% 149.79
Fibonacci 50% 142.22
Fibonacci 38.2% 134.65
Last Price 129.57
52-Week Low 110.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar